About CHEPLAPHARM
CHEPLAPHARM is a Healthcare company based in Mesekenhagen (Germany) founded in 1998 by Kurt Teubner. Branded pharmaceutical products are developed, marketed, and distributed globally. The company has 840 employees. Its website cheplapharm.com draws about 21 thousand monthly visits. CHEPLAPHARM offers products and services including Specialty Pharmaceutical Products. Its focus areas include Pharmaceutical Distributors, Diversified and Biopharma Outsourcing. Its legal entity is CHEPLAPHARM Arzneimittel GmbH. Its competitors include FundaMental Pharma, PHOENIX group and CeGaT; 1 of its 3 listed competitors has raised funding.
Company details
Cheplapharm was established in 1998 as a family-run pharmaceutical company headquartered in Mesekenhagen, Germany. Operations focus on the development, marketing, and distribution of branded products across various therapeutic areas. The portfolio has been expanded through strategic acquisitions and partnerships, supporting worldwide distribution. As a specialty pharmaceutical entity, investments are directed toward long-established brands in the sector.
- Headquarters Mesekenhagen, Germany
- Employees 840
- Founders Kurt Teubner
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website cheplapharm.com
- Social LinkedIn
- Legal Name Cheplapharm Arzneimittel Gmbh
- Latest Funding Round$547M (USD), Debt – Convertible
Oct 2022
- InvestorsHSBC
& 5 more
- Employee Count840
Products & Services of CHEPLAPHARM
CHEPLAPHARM offers a comprehensive portfolio of products and services, including Specialty Pharmaceutical Products.
Acquired and developed branded drugs for global markets
Funding Insights of CHEPLAPHARM
- Total Rounds 4
- Last Round Debt – Convertible — $547M
- First Round $71.96M
(Oct 2016)
- Investors Count 6
All 4 funding rounds of CHEPLAPHARM with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2022 | $547M | Debt – Convertible | – | GIC, Atlantic Park | – |
| Nov 2018 | $339.65M | Debt – Conventional | – | – | – |
| Jul 2018 | $911.98M | Debt – Conventional | – | – | |
| Oct 2016 | $71.96M | Debt – Conventional | – | – |
6 investors in total: 6 institutional.
Investors in CHEPLAPHARM
CHEPLAPHARM has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include HSBC, Deutsche Bank and UniCredit.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Sovereign wealth is managed and private equity investments are facilitated. | gic.com.sg | Singapore, Singapore | ||
| atlanticpark.com | ||||
A family office is operated across Nordic and European regions. | proventus.se | Stockholm, Sweden | ||
Diversified banking and financial services are provided globally. | 1870 | db.com | Frankfurt Am Main, Germany | |
Universal banking and financial advisory services are provided globally. | 1865 | hsbc.com | London, United Kingdom | |
Commercial bank | 1998 | unicreditgroup.eu | Milan, Italy |
Investor details for CHEPLAPHARM
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of CHEPLAPHARM
15 people are tracked at CHEPLAPHARM (9 in leadership, 6 in team); the tracked headcount is 840.
| Name | Role | Group |
|---|---|---|
Kurt Teubner | Founder | Leadership |
Klaus Köhl | COO | Leadership |
Edeltraud Lafer | Co-CEO | Leadership |
Sebastian Braun | Co-CEO | Leadership |
Christian Kerkhoff | Head Of Strategic Procurement - External Manufacturing | Leadership |
Ricardo Kressin | Global Head IT | Leadership |
Jens Schmidt | Director Human Resources | Leadership |
Daniel Grabowski | Head Of Recruiting & Personalmarketing | Leadership |
Sebastian Wäschle | Head Of Data And Information Management | Leadership |
Daniel Schumacher | Senior Executive Recruiter | Team |
Sascha Sommerfeld | Senior Strategic Procurement Manager | Team |
Dominik Brinkhaus | Senior Strategic Purchasing Manager | Team |
Andrea Eick | IT Project Manager | Team |
Daniel P. | Strategic Procurement Manager - Therapitic Area Cardiology | Team |
Wencke E. | Senior Data Scientist | Team |
Complete people profiles for CHEPLAPHARM
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of CHEPLAPHARM
3 dated milestones of CHEPLAPHARM across 24 years, from founding to its latest funding, stage changes and deals.
- Founded CHEPLAPHARM is founded.
- Funding First funding round of $72.0M.
- Funding Latest funding round, Debt – Convertible, of $547.0M.
Competitors of CHEPLAPHARM
CHEPLAPHARM has 3 listed competitors in our database, 1 of them funded. They include FundaMental Pharma, PHOENIX group and CeGaT.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| fundamentalpharma.com | 2016 | Heidelberg, Germany | $10.32M | Provider of drug development & research services for peptides & gene therapy, and neurological diseases | ||
| phoenixgroup.eu | 1994 | Frankfurt Am Main, Germany | 128 | Leading European provider of pharmaceutical wholesale, retail, and supply chain services. | ||
| cegat.com | 2002 | Tubingen, Germany | 113 | Provider of drug research and development services to develop genetic causes of rare diseases |
Detailed competitors of CHEPLAPHARM
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of CHEPLAPHARM
The website of CHEPLAPHARM (cheplapharm.com) receives about 21.2K visits a month and ranks #863,257 among all websites worldwide, #1,040 in Biotechnology and Pharmaceuticals.
- Monthly visits21.2K
▼ 25.9% vs previous month
- Unique visitors9.4K
per month
- Global rank#863,257
among all websites
- Category rank#1,040
Health · Biotechnology and Pharmaceuticals
- Bounce rate34%
- Pages per visit4.3
- Average visit4 min 58 sec
- DevicesDesktop 67% · Mobile 33%
Websites whose visitors overlap most with CHEPLAPHARM. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
eurim.de | eurim.de | 100% | #6,966,716 | – | |
mibe.de | mibe.de | 99% | – | ||
docpharm.de | docpharm.de | 98% | – | ||
| apomio.de | 76% | 32.8K | #825,842 | View details | |
disapo.de | disapo.de | 68% | #452,646 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 13 similar websites and full traffic analytics for CHEPLAPHARM
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cheplapharm
Complete news archive for CHEPLAPHARM
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CHEPLAPHARM
CHEPLAPHARM was founded in 1998 and raised its 1st funding round 18 years after it was founded.
CHEPLAPHARM is headquartered in Mesekenhagen, Germany. It is registered at Mesekenhagen, Mecklenburg-vorpommern, Germany.
CHEPLAPHARM has 840 employees.
Cheplapharm was established in 1998 as a family-run pharmaceutical company headquartered in Mesekenhagen, Germany. Operations focus on the development, marketing, and distribution of branded products across various therapeutic areas. The portfolio has been expanded through strategic acquisitions and partnerships, supporting worldwide distribution. As a specialty pharmaceutical entity, investments are directed toward long-established brands in the sector.
CHEPLAPHARM's top competitors include FundaMental Pharma, CeGaT and PHOENIX group.
CHEPLAPHARM offers Specialty Pharmaceutical Products.
CHEPLAPHARM has 6 investors. Key investors include HSBC, Deutsche Bank, UniCredit, GIC, and Atlantic Park.
CHEPLAPHARM operates through Cheplapharm Arzneimittel Gmbh.